Analyzing Financial Statements

𝗪𝗵𝗲𝗿𝗲 𝗶𝘀 𝘁𝗵𝗲 𝗥𝗲𝗮𝗹 𝗠𝗼𝗻𝗲𝘆 𝗶𝗻 𝘁𝗵𝗲 𝗚𝗹𝗼𝗯𝗮𝗹 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗖𝗮𝗻𝗻𝗮𝗯𝗶𝘀 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆? The global medical cannabis industry is growing, but the real financial success lies in a few key areas that go beyond cultivation alone. While many companies focus on volume or branding, the long-term profits come from precision, compliance, and innovation. Here are the areas where the real money is being made: 1. Pharmaceutical Development The most significant profits come from developing cannabis-derived medicines, particularly those aimed at treating serious conditions like epilepsy, chronic pain, and anxiety. Companies investing in clinical trials and regulatory approval can command premium pricing for certified medical products. 2. Genetic Cultivation and IP Owning the intellectual property of proprietary strains or developing new cannabinoid profiles that target specific medical conditions is highly valuable. Licensing these genetics or selling them at a premium provides a long-term revenue stream, similar to how pharmaceutical patents work. 3. EU GMP Manufacturing Facilities meeting EU Good Manufacturing Practice (GMP) standards are able to supply high-grade medical cannabis globally. This opens doors to major markets like the EU, where quality, safety, and consistency are paramount. Countries with GMP-certified facilities have a competitive advantage. 4. Research and Development Investing in research, whether it's isolating lesser-known cannabinoids or developing new delivery methods, is crucial for future profitability. As more medical uses for cannabis are discovered, the companies leading R&D will see significant financial returns. 5. Regulatory Navigation Companies that can successfully navigate complex international regulations to access major markets such as the U.S., Europe, and Australia are well-positioned. Meeting compliance standards like GACP and GMP ensures high-margin exports and access to a global patient base. 6. Healthcare Partnerships Building relationships with healthcare providers and insurance companies is another key area. Prescription cannabis is gaining acceptance in mainstream medicine, and companies that can integrate into healthcare systems are set to capture this lucrative market. 7. Technology and Data Utilising technology to optimise cultivation and gather patient data on cannabis efficacy is a growing area. Companies that leverage this data to show proven results will stand out to investors, regulators, and healthcare providers. In short, the real money in medical cannabis comes from innovation, compliance, and high-quality, scientifically backed products that can treat a range of conditions globally. #MedicalCannabis #PharmaceuticalCannabis #CannabisIndustry #CannabisResearch #CannabisInvestments #CannabisCompliance #GMP

3 Red Flags in Financial Statements That Most People Miss Most investors stop at the P&L. But the real story lies in the details. Here are 3 subtle but critical red flags to watch for: 1. Rising Profits but Falling Operating Cash Flow - Profits can be managed with accounting adjustments. - If a company shows strong earnings but weak cash generation, it’s a sign of aggressive revenue recognition. 2. Consistently Increasing Receivables - If sales are growing faster than actual cash collections, customers may not be paying on time. - This often signals weak credit control—or worse, inflated revenue. 3. High Debt Growth Without Matching Asset Growth - Debt is not bad if it funds expansion. - But if borrowings rise without a clear increase in productive assets, it could mean debt is covering operational shortfalls. Takeaway: Financial statements are more than numbers on paper. Learn to spot these patterns, and you’ll see risks before others do.

Revenue recognition may be amongst the most dangerous blind spots in high-growth startups today. When I moved from the corporate world into investing in startups I was told, rightly, that in the early days, product-market fit matters more than financial statements. But I've come to believe that revenue recognition, in particular, is often left for too late. That's risky, especially once a startup crosses a certain revenue threshold. Investors have the most leverage to set the tone for robust revenue recognition, yet the spotlight tends to be on growth metrics like user acquisition, retention, engagement, and GMV. These drive valuations and funding milestones, but when actual revenue - and how it's recognised - takes a backseat, it creates fragility. The golden rule is simple: be conservative with revenue recognition once revenues start to scale. This isn't about introducing enterprise-level financial controls at the seed stage, but ensuring that stage-appropriate governance kicks in at the right time. Unfortunately, even in well-funded growth-stage startups, this often gets neglected. Loose revenue recognition practices may not be fraudulent, but they can be misleading. Common red flags include: 1. Upfront recognition of multi-year contracts: Booking the entire value upfront instead of spreading it over time. 2. Immediate recognition of non-refundable upfront fees: Treating setup fees as revenue right away instead of over the customer lifecycle. 3. Gross vs. Net revenue: Reporting full transaction value instead of just the commission in marketplaces. 4. Channel stuffing: Inflating revenue by pushing unsold inventory to distributors. 5. Premature recognition of trial revenues: Recognising revenue during free trials before payment commitment. Of course, enforcing strict revenue recognition too early can mis-allocate precious startup resources and distract from product and customer priorities. But once a company reaches meaningful scale, deeply evaluating and strengthening accounting practices is a must-do – else it becomes a risk. The problem? No one around the table has a strong incentive to make this a priority. While investors can absorb losses through portfolio diversification, founders face reputational damage, and the broader impacts are severe: job losses, customer fallout, funding freezes, and sector-wide credibility damage. Good revenue recognition practices won't win pitch decks. But once you're scaling, they build resilience, credibility, and trust. The inflection point typically arrives around Series B, when investor scrutiny intensifies, enterprise customers become more common, and your financial story directly impacts valuation and credibility. #startups #founders #venturecapital  

🚩🚩🚩🚩🚩 Most startup financials I see have red flags you could spot from a mile away. Some of them are so glaring that, I can't even figure out how they were made... Here are 5 that has my ADHD screaming "fix me" — and why they matter: 🚩 Revenue ≠ GMV ≠ ARR First things first: Revenue is not GMV and it’s not (necessarily) ARR either. Stop lumping these numbers together. Your GMV might look impressive but if your take rate is only 10%, your actual revenue story is very different. Also, ARR only makes sense if your revenue is genuinely recurring (spoiler: one-off "projects" billed annually are not ARR). Misunderstanding this makes your business look bigger — but also way dumber — to investors. Get your definitions straight. It's not just semantics. It's credibility. 🚩 Reporting Burn Like It's EBITDA Early-stage founders often use EBITDA as a proxy for burn. It isn't. (Or it isn't for very long...) Burn tells you how much cash is leaving the bank each month. EBITDA tells you about operational profitability. If your business has COGS, capex, financing costs or deferred revenue, burn and EBITDA start to diverge — fast. If you're reporting burn as EBITDA, you're basically saying, "I haven't figured out how complex my business really is." 🚩 No Balance Sheet Look, I get it. Income statements are sexier and balance sheets are a pain. But if you show up to a board meeting, new round, or strategic review without a balance sheet? Immediate credibility hit. Balance sheets show you understand obligations, working capital, deferred revenues, debt loads — actual company health. Ignoring them is like trying to diagnose an illness by only looking at the patient's LinkedIn profile. 🚩 Confusion Around Gross Margin, Contribution Margin 1, and Contribution Margin 2 Your gross margin isn't the end of the story. Sophisticated businesses — especially ones with complex cost structures — need to break down: Contribution Margin 1: After variable costs directly tied to revenue. Contribution Margin 2: After semi-variable or tiered costs (e.g., sales commissions, platform fees). Most founders stop at Gross Margin... Good ones dig into Contribution Margins — because that's where the operational leverage lives. If you don't know where your margins actually inflect, scaling becomes guesswork. And that's dangerous. 🚩 (Bonus) Forecasts Based on Vibes, Not Fundamentals You know the type: "We'll 5x revenue next year because... <waves hands>!" No pipeline data. No CAC/LTV modelling. No unit economics sanity checks. Vibe-based forecasting is a luxury you can't afford beyond Seed stage. Hope is not a strategy. Bottom line: If you're serious about building something durable, your financials need to be just as strong as your product or team. Get this stuff right — or at least get someone on your side who can. (And if reading this made you think, "oh sh*t, we might have a few of these issues" — don't panic. Drop me a note. We'll fix it.) 😉

Inside the Footnotes: What Smart Analysts Dig for in Financial Reports Every analyst reads financial statements. Very few study the footnotes. But if you talk to senior bankers or investors, they will tell you that real insights often hide in those last few pages that most people skip. Here is how to train yourself to read footnotes like a professional. Step 1. Start with a clear question - Before opening the notes, decide what you are trying to understand. - Example: Is reported profitability sustainable? Are liabilities understated? Are there related-party risks? - Without a question, you will get lost in disclosures. With one, every line starts to make sense. Step 2. Go to the accounting policy section first This section tells you what rules of the game the company plays by. Check for: - Revenue recognition method (cash, delivery, or milestones) - Depreciation method and asset lives - Inventory valuation (FIFO, weighted average, or standard cost) - Capitalisation of expenses (especially R&D or interest) Why this matters: Accounting policy choices can inflate or deflate reported profits without changing the real business. Step 3. Review contingent liabilities - These are potential risks that are not yet booked as expenses. - Look for pending litigation, tax disputes, or guarantees. - Ask yourself, If even one of these materialises, what happens to cash flow or leverage? - This single habit can save you from overvaluing a business that looks healthy on the surface. Step 4. Scan related-party transactions - Footnotes often reveal dealings between promoters, subsidiaries, or family-owned entities. - Ask: Are the transactions priced at arm’s length? Are there loans or advances to related parties that never seem to reduce? - Patterns here tell you about governance quality more than any public statement. Step 5. Look for non-recurring items in notes to P&L Companies often hide “one-time” gains or losses in footnotes like - Asset sale gains - Legal settlements - Inventory write-downs - Restructuring expenses - Mark them. Adjust your EBITDA or EBIT accordingly. You are now working with a cleaner, more accurate base. Step 6. Read debt and lease disclosures together - Check total debt split into short-term and long-term. - Then read lease commitments and off-balance-sheet obligations. - This gives you a truer picture of leverage than headline debt numbers. Step 7. Connect notes to the three statements - Every line in the notes should link back to an account on the Balance Sheet, P&L, or Cash Flow. - If something does not reconcile, that is a flag. - For example, if goodwill impairment is discussed in notes but not visible in P&L, you know there is a gap to question. Step 8. Write a 3 line Footnote Summary After reviewing, write three short points: - What surprised me? - What could change my valuation? - What should I track next quarter? That is how you turn static reading into active analysis Next Live Batch starts from Nov 9th

Data is only powerful if people understand and act on it That’s why just pulling numbers isn’t enough. A good report tells a story, answers key business questions, and helps decision-makers take action. To ensure your analysis actually gets used: ✅ Start with the right question – If you don’t understand what stakeholders really need, you’ll spend hours on the wrong metrics. It’s okay to ask clarifying questions. ✅ Make it simple, not just accurate – Clean tables, clear charts, and insights that anyone (not just data people) can understand. ✅ Provide context, not just numbers – A 20% drop in sales is scary… unless you also show seasonality trends and explain why it’s normal. ✅ Anticipate follow-up questions – The best reports answer the next question before it's asked. ✅ Know your audience – A C-suite executive and a product manager don’t need the same level of detail. Tailor accordingly. Your work should make decision-making easier. If stakeholders are confused, they won’t use your report No matter how technically correct it is. The best data professionals don’t just crunch numbers. They translate data into impact. Have you ever spent hours on an analysis only for no one to use it?

𝐀𝐧𝐚𝐥𝐲𝐳𝐢𝐧𝐠 𝐅𝐢𝐧𝐚𝐧𝐜𝐢𝐚𝐥𝐬 𝐋𝐢𝐤𝐞 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐁𝐚𝐧𝐤𝐞𝐫𝐬 1️⃣ Start with the Big Picture Understanding the broader context is essential. Industry Dynamics: What macroeconomic factors, competitive forces, and regulatory changes impact the company Business Model: How does the company make money? Is its revenue model scalable and sustainable Management's Narrative: Read annual reports, investor calls, and press releases. Do the financials align with the story management is telling A mismatch between the narrative and the numbers can be your first red flag. 2️⃣ Examine the Revenue in Detail Revenue quality is the foundation of any valuation. Ask yourself: Are revenue streams diversified, or is the company overly dependent on a few customers or products? Are there unusual spikes, seasonality, or growth patterns Check accounts receivable—are they growing faster than revenue This could signal aggressive revenue recognition. 3️⃣ Scrutinize Expenses for Insights Drill into cost structures and compare trends over time: Cost of Goods Sold (COGS): Are margins consistent, or do they show unexpected variability Operating Expenses: Is there a logical correlation between spending (e.g., marketing, R&D) and growth outcomes Discretionary Expenses: Watch for unusual spending patterns or inflated overheads, which may hide inefficiencies or fraud. Compare expense ratios to industry benchmarks to identify outliers. 4️⃣ Follow the Cash "Cash is king" isn't just a saying—it's a fundamental truth. Analyze the cash flow statement, focusing on operating cash flow. Does cash generation align with reported profits? If not, investigate why. Working Capital: Examine receivables, payables, and inventory turnover. High receivables or slow collections can strain liquidity. A company’s survival depends on cash, not profits, so inconsistencies here are critical. 5️⃣ Detect Red Flags in Accounting Practices Deep-dive into financial statement notes and management assumptions: Revenue Recognition Policies: Changes or overly aggressive assumptions can inflate top-line growth. Capitalization of Expenses: Are expenses being shifted to the balance sheet to boost short-term profitability Frequent “Non-Recurring” Charges: If restructuring costs, write-offs, or "one-time" adjustments recur year after year, take note. Off-Balance Sheet Items: Unrecorded liabilities or guarantees can inflate the company’s financial health. 6️⃣ Benchmark Against Peers Comparing the company to industry peers helps contextualize its performance. Look at: Margins: Are gross, operating, and net profit margins in line with the industry? Leverage: How does the debt-to-equity ratio compare Growth Rates: Is the company growing faster, slower, or on par with competitors Deviations can signal either unique strengths—or risks that need deeper investigation. LinkedIn LinkedIn Guide to Creating

10 Mistakes I made during my 13 years of Equity research and how I corrected them – I am telling you all so that you don’t make the same mistakes I do! 1 – Falling in love with stocks - Held on even when data turned against me. Always have an exit in mind. If a fundamental change occurs, exit the stock, no emotions! 2 - Relying Too Much on Management Commentary - Took their words at face value. Always verify what management says and see if they achieve it. If they fail to achieve their goals many times, consider exiting. 3 - Ignoring Cash Flow - Got impressed by growth, while ignoring Cash Flow from Operations and Free Cash Flows. Now, FCF is the first number I check after revenue and PAT growth. Also, check the EBITDA to Cash Flows conversion. 4 – Chasing Short-Term Noise – Was getting disturbed by many headlines and price moves. Now I focus mainly on fundamentals. 5 – Not Networking Enough - Relied too much on own analysis. Now I speak regularly to promoters, peers, analysts, and industry experts—a better perspective, faster learning. I also do a lot of plant visits. 6 - Created a structured review calendar—quarterly deep dives, not daily knee-jerks. 7 - Underestimating Risks - Focused only on upside in reports/analysis. Earlier, I used to try to find positives in every company; now I try to find only negatives – this simple step will change your world of Equity research – think of it as a Negative Filtration list! 8 – Not Writing/Not Documenting My Thought Process - Forgot why I took certain calls months later. I now maintain entry and exit notes and other sectoral notes for easy access to rationale, risks, and triggers. 9 - Skipping Continuous Learning – I got comfortable after early success. But the day you think everything in markets, your career as an investor/Equity researcher is over. Now, I read across various sectors, geographies, and asset classes—learning never stops. 10 - Overlooking Position Sizing - Even if my research was right, I took small bets. I size positions based on conviction and risk, not excitement. Position Sizing is khaas, baaki sab bakwaas! I hope this helps. All the best!

RED FLAGS IN FINANCIAL STATEMENTS: A GUIDE TO SPOTTING TROUBLE EARLY💡 Analyzing financial statements is crucial for understanding a company's health. Here are some key warning signs that demand attention: Red Flags in Financial Statements: What to Watch For Have you spotted other red flags in your experience? Share your insights in the comments below! INCOME STATEMENT: 1. Declining Revenues - Indicates a potential drop in demand or loss of competitive edge. 2. Increasing Operating Expenses - Suggests inefficiencies or rising costs that erode profitability. 3. Net Losses - Repeated losses hint at an unsustainable business model. 4. Unusual Revenue Sources - Irregular or one-time income can mask core business issues. 5. Inconsistent Earnings - Volatility in profits might indicate unreliable operations. 6. High Interest Expenses - Excessive debt burden can hinder growth. BALANCE SHEET: 1. High Debt Levels - Over-leverage can lead to financial strain during downturns. 2. Negative Equity - A sign that liabilities exceed assets, eroding shareholder value. 3. Declining Asset Quality - Impaired assets reflect poor investment or aging equipment. 4. Increasing Accounts Receivable - Could indicate difficulty collecting payments. 5. High Inventory Levels - Risk of obsolescence or inefficient inventory management. 6. Short-Term Debt - Heavy reliance on short-term borrowing increases risk. CASH FLOW STATEMENT: 1. Negative Operating Cash Flow - Signals that the core business is not generating cash. 2. High Capital Expenditures - While growth related, excessive spending can strain liquidity. 3. Frequent Financing Activities - Reliance on external funding points to cash flow issues. 4. Mismatch Between Net Income and Cash Flow - Accounting anomalies or unsustainable earnings. 5. Negative Free Cash Flow - Lack of surplus cash for growth or debt repayment. 6. Large Dividends Despite Negative Cash Flow - Suggests unsustainable shareholder payouts. These indicators help investors, analysts, and stakeholders identify potential risks early. #CashFlow #BusinessFinance #FinancialManagement #Accounting #Investing #OperatingActivities #FinancingActivities #BusinessGrowth #FinancialLiteracy #CorporateFinance #CashFlowManagement #FinanceTips #SmallBusinessFinance #Entrepreneurshi #BusinessInsights #InnocentTax #InnocentAccountant #InnocentMotivated #InnocentLinkedin

In the world of finance, identifying red flags early can protect your business from significant risks. Here are key indicators to watch for in your financial statements 🚨 📈 Income Statement - Declining Revenues: Consistent drop in revenue over multiple periods. - Decreasing Gross Margin: Gross margin percentage is shrinking. - Increasing Operating Expenses: Operating expenses rising faster than revenue. - Net Losses: Sustained net losses over several periods. - Unusual Revenue Sources: Significant one-time income items. - High Interest Expenses: Large portion of income going towards interest. 📊 Balance Sheet - High Debt Levels: Excessive debt-to-equity ratio. - Negative Equity: Liabilities exceed assets. - Declining Asset Quality: Frequent write-downs or impairments. - Increasing Accounts Receivable: Accounts receivable growing faster than sales. - High Inventory Levels: Inventory increasing without sales growth. - Short-Term Debt: High proportion of short-term liabilities. - Off-Balance Sheet Liabilities: Significant off-balance sheet liabilities. 💵 Cash Flow Statement - Negative Operating Cash Flow: Consistently negative cash flow from operations. - High Capital Expenditures: Large capital expenditures without corresponding cash inflows. - Frequent Financing Activities: Regular reliance on borrowing or equity issuance. - Cash Flow Discrepancies: Significant differences between net income and cash flow. - Negative Free Cash Flow: Negative free cash flow over multiple periods. - Large Dividends Despite Negative Cash Flow: Dividends paid out despite negative operating cash flow. - Cash Flow Volatility: Irregular or highly fluctuating cash flows. These are just a few examples. Always investigate the reasons behind these indicators to understand the full picture. 📊🔍 𝗣.𝗦. Financial analysis is only one part of comprehensive business management. Stay informed and vigilant to keep your business on the path to success! Follow me Sadaf Abbas for more content like this #FinancialAnalysis #Accounting #CashFlow #IncomeStatement #BalanceSheet